Evidence map›Paper›PMID 27764132›Full record

ArticlePloS one2016

Can We Spare the Pancreas and Other Abdominal Organs at Risk? A Comparison of Conformal Radiotherapy, Helical Tomotherapy and Proton Beam Therapy in Pediatric Irradiation.

Emmanuel Jouglar, Antoine Wagner, Grégory Delpon, Loïc Campion, Philippe Meingan, Valérie Bernier, Charlotte Demoor-Goldschmidt, Marc-André Mahé, Thomas Lacornerie, Stéphane Supiot

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Convolutional neural network-based automatic liver delineation on contrast-enhanced and non-contrast-enhanced CT images for radiotherapy planning.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Emmanuel JouglarDepartment of Radiation Oncology, Institut de Cancérologie de l'Ouest, boulevard Jacques Monod, Saint Herblain, 44800 France.
Antoine WagnerDepartment of Medical Physics, Centre Oscar Lambret, 3 rue Frédéric Combemale, Lille, 59000 France.
Grégory DelponDepartment of Medical Physics, Institut de Cancérologie de l'Ouest, boulevard Jacques Monod, Saint Herblain, 44800 France.
Loïc CampionDepartment of Statistics, Institut de Cancérologie de l'Ouest, boulevard Jacques Monod, Saint-Herblain, 44800 France.
Philippe MeinganDepartment of Radiology, Institut de Cancérologie de l'Ouest, boulevard Jacques Monod, Saint-Herblain, 44800 France.
Valérie BernierDepartment of Radiation Oncology, Institut de Cancérologie de Lorraine, 6 Avenue de Bourgogne, Vandœuvre-lès-Nancy, 54519 France.
Charlotte Demoor-GoldschmidtDepartment of Radiation Oncology, Institut de Cancérologie de l'Ouest, boulevard Jacques Monod, Saint Herblain, 44800 France.
Marc-André MahéDepartment of Radiation Oncology, Institut de Cancérologie de l'Ouest, boulevard Jacques Monod, Saint Herblain, 44800 France.
Thomas LacornerieDepartment of Medical Physics, Centre Oscar Lambret, 3 rue Frédéric Combemale, Lille, 59000 France.
Stéphane SupiotDepartment of Radiation Oncology, Institut de Cancérologie de l'Ouest, boulevard Jacques Monod, Saint Herblain, 44800 France.
Institut de Cancérologie de l'Ouest · FRCentre Oscar Lambret · FRInstitut de Cancérologie de Lorraine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesLate abdominal irradiation toxicity during childhood included renal damage, hepatic toxicity and secondary diabetes mellitus. We compared the potential of conformal radiotherapy (CRT), helical tomotherapy (HT) and proton beam therapy (PBT) to spare the abdominal organs at risk (pancreas, kidneys and liver- OAR) in children undergoing abdominal irradiation.

methodsWe selected children with abdominal tumors who received more than 10 Gy to the abdomen. Treatment plans were calculated in order to keep the dose to abdominal OAR as low as possible while maintaining the same planned target volume (PTV) coverage. Dosimetric values were compared using the Wilcoxon signed-rank test.

resultsThe dose distribution of 20 clinical cases with a median age of 8 years (range 1-14) were calculated with different doses to the PTV: 5 medulloblastomas (36 Gy), 3 left-sided and 2 right-sided nephroblastomas (14.4 Gy to the tumor + 10.8 Gy boost to para-aortic lymphnodes), 1 left-sided and 4 right-sided or midline neuroblastomas (21 Gy) and 5 Hodgkin lymphomas (19.8 Gy to the para-aortic lymphnodes and spleen). HT significantly reduced the mean dose to the whole pancreas (WP), the pancreatic tail (PT) and to the ipsilateral kidney compared to CRT. PBT reduced the mean dose to the WP and PT compared to both CRT and HT especially in midline and right-sided tumors. PBT decreased the mean dose to the ispilateral kidney but also to the contralateral kidney and the liver compared to CRT. Low dose to normal tissue was similar or increased with HT whereas integral dose and the volume of normal tissue receiving at least 5 and 10 Gy were reduced with PBT compared to CRT and HT.

conclusionIn children undergoing abdominal irradiation therapy, proton beam therapy reduces the dose to abdominal OAR while sparing normal tissue by limiting low dose irradiation.

Indexed as

Abdominal CavityAdolescentChildChild, PreschoolFemaleHumansInfantKidneyLiverMaleOrgans at RiskPancreasProton TherapyRadiotherapy, ConformalRadiotherapy DosageRadiotherapy, Intensity-Modulated

Identifiers

PMID27764132
PMCPMC5072698
OpenAlexW2535985766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.